NCT02214888View on ClinicalTrials.gov

Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets in Patients With Active Rheumatoid Arthritis

PHASE2TerminatedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

January 31, 2004

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

BIRB 796 BS, low dose

DRUG

BIRB 796 BS, high dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY